Gara Jalqabaatti › Epidermolysis Bullosa Dystrophica › California
Qorannoo klinikaalii Epidermolysis Bullosa Dystrophica California keessatti
Qorannoo 7 Epidermolysis Bullosa Dystrophica f California keessatti hirmaatuu jiru.
Magaalota California keessatti
Takkalaa qorannoo (Ingiliffa)
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
- Lucile Packard Children's Hospital, Palo Alto
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06423573A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting
- Lucile Packard Children's Hospital, Palo Alto
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT07700966Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
- Stanford University, Redwood City
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 6 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06834035Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
- Stanford University School of Medicine, Stanford
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 24-Elb-2026 · NCT01019148A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
- Mission Dermatology Center, Rancho Santa Margarita
Namoota walitti qabaa jiraSadarkaa 3
6 Months · Saalaa hunda · Haaromfame 12-Bit-2026 · NCT07016750MSC EVs in Dystrophic Epidermolysis Bullosa
- USC /Norris Comprehensive Cancer Center University of Southern California, Los Angeles
Namoota walitti qabaa jiraSadarkaa 1/2
6 Months · Saalaa hunda · Haaromfame 25-Wax-2025 · NCT04173650Long-Term Follow-up Protocol
- Mission Dermatology Center, Rancho Santa Margarita
- Stanford University, Redwood City
Namoota walitti qabaa jiraQorannoo ilaalaa
6 Months · Saalaa hunda · Haaromfame 08-Wax-2021 · NCT04917887Kanneen ClinicalTrials.gov irraa argaman, daataa 07-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.